3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|12|3|219-233

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.12, Iss.3, 2014-12, pp. : 219-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 270-286

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Molecular Docking Studies of Flavonoid Derivatives as Potent Acetylcholinesterase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 10, 2015-12 ,pp. : 837-7

Bentham Science Publishers

Access to resources Recommend Favorite

Combined 3D-QSAR, Pharmacophore and Docking Studies on Benzenesulfonamide Derivatives as Potent 12-Lipoxygenase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 74-82

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies of 4-morpholinopyrrolopyrimidine Derivatives as Potent mTOR Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 4, 2011-05 ,pp. : 339-354

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies on Pyrrolopyrimidine Derivatives as LIM-Kinase 2 Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-01 ,pp. : 229-240

Bentham Science Publishers

Access to resources Recommend Favorite